<DOC>
	<DOC>NCT01832610</DOC>
	<brief_summary>Patients will be approached to participate in this PAS after the HeartWare® Ventricular Assist System receives PMA approval for the indicated use as a bridge to cardiac transplantation. Patients who participated in prior trials will be approached for this PAS as follows: - Patients who are on continued HeartWare® System support, (original or exchange device) - Patients who have been explanted for transplant or recovery and have not yet completed 6 months of follow-up Patients who participated in prior trials who will not be approached to participate in this follow-up study include: • Patients who have been explanted for transplant or recovery and have completed at least 6 months of follow-up (documented in the prior IDE trial). No new patients are being screened or implanted with the HeartWare® System for this trial, it is a follow-up trial only.</brief_summary>
	<brief_title>Post- Approval Study on Patients Who Received a HeartWare HVAD® During IDE Trials</brief_title>
	<detailed_description />
	<mesh_term>Heart Failure</mesh_term>
	<criteria>1. The patient has participated in a prior HeartWare trial under IDE G070199. 2. The patient was implanted with the HeartWare® Ventricular Assist System and was an active patient in the prior trial. 3. The patient has signed informed consent for participation in the study. 1. The patient is unwilling or unable to comply with trial requirements. 2. The patient did not sign the informed consent.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2015</verification_date>
</DOC>